lamellarins (PharmaMar)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namelamellarins (PharmaMar)
Drug Alias Namelamellarin Dlamellarin N triacetatelamellarin Ilamellarin Mlamellarin K +[11] 
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionDNA topoisomerase I inhibitors
TargetsDNA topoisomerase I
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharma Mar Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharma Mar Sa
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A